skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8830

A critical dialogue: communicating with type 2 diabetes patients about cardiovascular risk

(2125) Views  (424) Full article downloads

Authors: Paris Roach, David Marrero

Published Date January 2005 Volume 2005:1(4) Pages 301 - 307
DOI: http://dx.doi.org/10.2147/VHRM.S

Paris Roach, David Marrero

Department of Medicine, Division of Endocrinology and Metabolism, Indiana University School of Medicine, Indianapolis, IN, USA

Abstract: Patients with type 2 diabetes mellitus (DM) are at increased risk for cardiovascular disease (CVD), and many patients are inadequately treated for risk factors such as hyperglycemia, hyperlipidemia, hypertension, and smoking. Providing individualized risk information in a clear and engaging manner may serve to encourage both patients and their physicians to intensify risk-reducing behaviors and therapies. This review outlines simple and effective methods for making CVD risk infomation understandable to persons of all levels of literacy and mathematical ability. To allow the patient to understand what might happen and how, personal risk factors should be clearly communicated and the potential consequences of a CVD event should be presented in a graphic but factual manner. Risk calculation software can provide CVD risk estimates, and the resulting information can be made understandable by assigning risk severity (eg, “high”) by comparing clinical parameters with accepted treatment targets and by comparing the individual’s risk with that of the “average” person. Patients must also be informed about how they might reduce their CVD risk and be supported in these efforts. Thoughtful risk communication using these techniques can improve access to health information for individuals of low literacy, especially when interactive computer technology is employed. Research is needed to find the best methods for communicating risk in daily clinical practice.

Keywords: cardiovascular disease, type 2 diabetes, cardiovascular risk, risk communication








Readers of this article also read:

Knowledge of risk factors and warning signs of stroke
Combining insulins with oral antidiabetic agents: effect on hyperglycemic control, markers of cardiovascular risk and disease
Fosphenytoin for the treatment of status epilepticus: an evidence-based assessment of its clinical and economic outcomes
Cardiovascular disease and intensive glucose control in type 2 diabetes mellitus: moving practice toward evidence-based strategies
Mitigating micro- and macro-vascular complications of diabetes beginning in adolescence
Cost-effectiveness analysis of corticosteroid inhaler devices in primary care asthma management: A real world observational study
Reference values of hematological indices of infants, children, and adolescents in Port Harcourt, Nigeria
Sensitization with atypical mycobacteria is a potent risk factor for cross-reaction with the delayed type hypersensitivity assay in mice
Optimal management of testicular cancer: from self-examination to treatment of advanced disease
Nanostructured delivery system for zinc phthalocyanine: preparation, characterization, and phototoxicity study against human lung adenocarcinoma A549 cells
  • Join ISVH

    Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University